Reference
Pfeuffer S, et al. Acalculous cholecystitis as an infusion-related reaction in alemtuzumab-treated RRMS patients. Long-term follow-up and conversion to chronic disease. Multiple Sclerosis Journal 23 (Suppl. 1): 915 abstr. EP1737, No. 3, Oct 2017. Available from: URL: http://doi.org/10.1177/1352458517731285 [abstract] - Germany
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1681, 21 (2017). https://doi.org/10.1007/s40278-017-39297-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-39297-y